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At present Poland is well satura ted with invasive cardiol-
ogy centres that are equally distributed across the country. The 
national percutaneous coronary intervention (PCI) database 
(ORPKI) identifies as many as 155 such centres in 2015, 
which makes it well in line with the European Society of 
Cardiology (ESC) recommendations of at least one catheteri-
sation laboratory per 300,000–1,000,000 inhabitants [1, 2]. 
The well-planned development and organisation of invasive 
cardiology in the last two decades has brought Poland to the 
third place in Europe in terms of number of primary PCI in 
ST elevation myocardial infarction (STEMI) per million inhabitants 
per year and has led to the fulfilment of all criteria required by 
the “Stent for Life” initiative [3]. The quality of percutaneous 
treatment of patients in Poland has improved and grown in 
numbers, and has followed international trends in the adop-
tion of modern PCI techniques and utilisation of novel devices 
and medications [4]. Nevertheless, the incidence rates of new 
onset myocardial infarction (MI) are still higher in Poland than 
in Western Europe [5, 6]. At the same time, some disturbing 
data on the long-term outcome of patients after MI in Poland 
have been published [5]. Although the in-hospital mortality in 
acute MI has decreased in recent years in all age groups, the 
mortality after discharge and up to one year is still high (up to 
21% in those treated conservatively; overall 10.1%), but this 
depends on the mode of treatment (lowest in patients treated 
initially with PCI — 6.5%). These recent data confirm that 
both primary and secondary prevention measures in general 
are ineffective and fail in their current form to bring us closer 
and faster to European counterparts, and more effort and 
a nationwide approach need to be made to improve them. 
Current ESC STEMI guidelines provide only general 
measures in secondary prevention like lifestyle changes (diet 
and weight control or smoking cessation) and focus mainly on 
pharmacotherapy [1]. A more detailed approach, however, is 
discussed in the 2012 ESC prevention guidelines [7]. These 
stress the necessity of a population-based approach to sec-
ondary prevention as recommended by the National Institute 
for Health and Care Excellence and underline the role of 
sustained contact with patients and their adherence to preven-
tion schemes, triggering motivation, establishing cooperation 
with non-governmental organisations with a special focus on 
nurses’ coordinated programmes with healthcare providers 
and helping to launch self-help patient groups. The most im-
portant conclusion from the above-mentioned guidelines is 
the fact that all of these pay off in terms of cost–effectiveness 
analysis. Specific Polish recommendations on prevention were 
published in 2013 and provide a detailed approach to patients 
after acute coronary syndromes (ACS), bypass surgery, and 
heart failure. Both cardiac rehabilitation and education are 
advised at different phases of these prevention programmes 
[8]. The authors of this proposed optimal and complex model 
of secondary prevention underline the fact that such measures 
have already been positively tested in the Polish population in 
the EUROACTION project [9]. Nevertheless, further studies 
revealed that the implementation of secondary prevention 
guidelines in patients after hospitalisation for coronary artery 
disease in Poland noted a modest improvement only in blood 
pressure control [10]. In fact, the proportion of patients after 
unstable angina or PCI who were advised in the prevention 
programme decreased significantly in Poland in 2012 com-
pared to 2006. What is also interesting, the proportion of 
oral advice given by medical personnel decreased in favour 
of printed materials handed out to patients. It seems that 
a modern substitute was chosen more often since it is always 
easier to give out booklets than to actually speak to the pa-
tients and answer their questions. In the end, the prevalence 
of cardiovascular risk factors in Poland is still based on quite 
old data from the WOBASZ study, but hopefully new data will 
become available soon to see if any changes have occurred 
during the last decade [11]. 
All of the above mentioned led to the development of 
a unique secondary prevention programme of a Patient Club 
in south and eastern Poland in 2011 adopted by 13 interven-
tional cardiology centres [12]. The idea of patient educational 
meetings held 1–2 months after ACS or PCI, which encompass 
not only lectures and advice given by doctors and nurses but 
also cardiopulmonary resuscitation training and hands-on PCI 
simulation with an opportunity to meet patients from different 
centres and socialise during Nordic walking sessions or once 
a year during a Central Patient Club in Krakow have proven 
to be successful in terms of reduction of hazardous habits and 
increasing healthy lifestyle changes. The initial experience of the 
Polish Patient Club was discussed with our Norwegian partners 
during a two-day seminar held in Krakow on March 27–28, 
2015. Oslo University Hospital (OUS), Ullevål, Oslo, Norway 
has developed a secondary prevention programme for patients 
hospitalised for ACS. They arrange monthly Heart School meet-
ings for patients and their relatives who have experienced an 
ACS, lasting for one day. Information about the Heart School 
programme and coronary heart disease in general is given 
by a specially trained nurse at the beginning of this meeting. 
A cardiologist then presents information about coronary heart 
disease, risk factors, treatment with PCI, and coronary arte-
rial bypass surgery. The most frequently used cardiovascular 
medications, how they work, and the most common side ef-
fects are also discussed by a pharmacologist. The participants 
are encouraged to be active and present their own questions, 
experiences, and worries. Then a nutritionist gives advice about 
dietary matters, and a physiotherapist informs the patients 
about physical activity after ACS. At the end of day an equally 
matched person has some time to discuss any issues that were 
not mentioned earlier. Early after discharge from the hospital, 
patients are also invited to participate in a group-based exercise 
training programme guided by a physiotherapist, 2–3 times 
a week for 8–12 weeks, based on the Norwegian Ullevål model 
[13]. Patients with increased risk for recurrent coronary events 
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are referred to the Department of Preventive Cardiology, OUS 
for further evaluation of risk factors and intervention. 
Based on Polish and Norwegian experiences, a new 
optimal model of patient education after ACS treated in inter-
ventional cardiology centres was introduced and was unani-
mously approved by patient representatives from cardiology 
departments participating in the Patient Club initiative during 
the Polish–Norwegian seminar in Krakow. The suggested Heart 
School model that we introduced focuses on intense educa-
tional programme for patients and their family members at an 
early stage after hospital discharge (Fig. 1). We believe that the 
optimal timing for such intervention is 3–7 days after PCI for 
ACS. Earlier education in hospital may not be effective due to 
the stressful situation caused by ACS and the lack of time by 
medical staff during discharge, as well as the patient’s desire 
to return home as quickly as possible. On the other hand, 
later educational intervention (four weeks and later) may be 
insufficient due to the fact that patients may already return to 
their bad habits and feel safe in terms of further morbidity. The 
Patient Club meetings were certainly beneficial but insufficient 
in terms of optimal timing of the intervention. The Heart School 
is a comprehensive approach to proper education for second-
ary prevention in cardiovascular diseases. We do not contradict 
the already existing rehabilitation schemes provided by the ESC 
nor any Polish authors but wish to enhance and fill in the miss-
ing gaps. The first innovative Heart School has already been 
launched in Poland and we hope that the model will spread 
and evolve based on physicians’ and patients’ feedback. We 
plan to publish the first scientific data on its benefits in 2016.
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Figure 1. Heart School programme of secondary prevention; 
ACS — acute coronary syndrome; BMI — body mass index;  
BP — blood pressure; HR — heart rate
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